Kura Oncology (NASDAQ:KURA) stock slid 17% post-market after the company announced a collaboration deal with Japan's Kyowa Kirin (OTCPK:KNBWY) for its leukemia drug candidate ziftomenib worth up ...

Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute leukemia, the companies said Wednesday. Kyowa ...

(RTTNews) - Kura Oncology Inc. (KURA) said that it has entered into a global strategic collaboration with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib, Kura's selective oral menin ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hullo! Today, some squiddy drug delivery, a leukemia deal between Kura ...

Kura Oncology announced on Wednesday that it will collaborate with Japan’s Kyowa Kirin to develop and commercialize the blood cancer therapy ziftomenib. According to the company’s statement ...

Kelezatan hidangan yang khas dengan kuah santan kental ini hadir dalam dua varian utama: opor dengan bumbu kuning yang kaya akan kunyit, dan opor dengan bumbu putih yang mengandalkan kesegaran ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The FDA recently approved the first drug in a new class of leukemia medicines. Kura Oncology’s endeavor to follow that newly blazed regulatory trail is now infused with $330 million from a ...

Alat dapur yang satu ini juga hadir dalam beragam bentuk, ukuran, dan material, mulai dari yang berbahan dasar kayu, plastik, bambu ... dengan mudah kamu temukan di toko offline maupun online. Gambar ...